Immunoreactivity

Show results for

Unknown (3436)
Transcriptomics (107)
Genomics (97)
Proteomics (36)
Methylation profiling (2)
Clinical (1)
Other (1)
Metabolomics (1)

Organisms

Mus musculus (59)
Homo sapiens (54)
Andropogon gerardi (17)
Bacteria (17)
Borrelia (17)
Botrytis cinerea (17)
Canis lupus familiaris (17)
Clostridium perfringens (17)
Cnidaria (17)
Cricetulus griseus (17)
Eukaryota (17)
Fasciola (17)
Hepatitis B virus (17)
Human betaherpesvirus 5 (17)
Japanese encephalitis virus group (17)
Miscanthus x giganteus (17)
Rattus norvegicus (6)
Danio rerio (2)
Thalassiosira pseudonana (1)
Neisseria meningitidis (1)
Cricetulus griseus (1)
Rattus (1)
Ovis aries (1)
Bos taurus (1)
Naja philippinensis (1)
Naja sumatrana (1)
Ovophis convictus (1)
Ovophis okinavensis (1)
Ovophis tonkinensis (1)
Popeia (1)

Organisms

Mus musculus (38)
Homo sapiens (35)
Rattus norvegicus (2)
primate metagenome (1)
Triticum (1)
Rattus (1)
Triticum aestivum (1)
Bos taurus (1)
Danio rerio (1)
Ovis aries (1)

Repository

ENA (92)
geo (65)
biostudies-arrayexpress (56)
pride (17)
MassIVE (6)
iProX (4)
EGA (1)
jPOST (1)
MetaboLights (1)
PanoramaPublic (1)

Tissue

Cell culture (3)
Brain (2)
Venom (2)
Blood (1)
Blood cell (1)
Blood plasma (1)
Bone (1)
Bone tissue (1)
Endothelial cell (1)
Epithelial cell (1)
Eye (1)
Heart (1)
Liver (1)
Myofibroblast cell (1)
Primary cell (1)
Smooth muscle myoblast (1)
Tongue cancer cell line (1)

Disease

Atypical lung carcinoid (1)
Adenocarcinoma (1)
Head and Neck Neoplasms (1)
Aortic valve stenosis (1)
Bone osteosarcoma (1)
Candidiasis (1)
Malaria (1)
Myopathy (1)
Oral cavity cancer (1)
Wilson disease (1)

Technology Type

Mass Spectrometry (17)
Shotgun proteomics (10)
Bottom-up proteomics (4)
Gel-based experiment (2)
Mass spectrometry assay (1)
All-ion fragmentation (1)
Data-independent acquisition (1)

Instrument Platform

GenePix4000B (1)
Illumina HiSeq 4000 (1)
NextSeq 500 (1)
LTQ Orbitrap (1)
MS:1000031 (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Orbitrap Fusion Lumos (1)
Q Exactive Plus (1)
Ultraflex III TOF/TOF (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2015 (21)
2025 (13)
2026 (12)
2014 (10)
2013 (10)
2022 (10)
2021 (9)
2012 (9)
2023 (8)
2011 (6)
2024 (6)
2019 (6)
2018 (6)
2010 (5)
2008 (5)
2009 (4)
2020 (4)
2017 (2)
2016 (2)
2007 (2)

Metabolite Name

(-)-Epothilone E (1)
(-)-Isobebeerine (1)
(-)-trans-C75 (1)
(+)-(E,E)-3-Hydroxy-7-phenyl-4,6-heptadienic acid (1)
(+)-Neomethynolide (1)
(+)-Prosopinine (1)
(+)-Rauflorine (1)
(+/-)-lefetamine (1)
(1R,4R)-p-Mentha-2,8-dien-1-ol (1)
(1S,2R,5S,6R)-5,6-dihydroxy-2-methylcyclohex-3-enecarboxylic acid|massarigenin E (1)
(1S,4S)-4-Hydroxy-3-oxocyclohexane-1-carboxylate (1)
(2S)-2r,8c,17t-triisobutyl-5c,11c,14t-triisopropyl-7-methyl-1,4,10-trioxa-7,13,16-triaza-cyclooctadecane-3,6,9,12,15,18-hexaone|cyclo-(L-2-hydroxy-3-methyl-butyryl->N-methyl-L-leucyl->L-2-hydroxy-3-methyl-butyryl->D-valyl->D-leucyl->L-2-hydroxy-4-methyl-pentanoyl)|Pimaydolid|pimaydolide (1)
(2S)-methylbutanenitrile (1)
(2S,3R,4R,5S,6S)-2-(Hydroxymethyl)-6-phenylmethoxyoxane-3,4,5-triol (1)
(2S,3S,4R,5R)-2,5-epoxy-3,4-dimethyl-8,9-methylenedioxy-10-methoxy-6,11-benzocycloheptan-1-one|gymnothedelignan A (1)
(5R,6E)-5-Hydroxy-1,7-Diphenyl-6-Hepten-3-One (1)
(6S,8S)-5,6,7,8-tetrahydro-1,3,6-trihydroxy-6-acetyl-8-methylnaphthalene-4-carboxylic acid|ficuselastic acid (1)
(8R,9R,10S,13S,14S)-13-Methyl-1,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene (1)
(E)-10a-(2-(allyloxy)styryl)-10,10-dimethyl-3,4,10,10a-tetrahydropyrimido[1,2-a]indol-2-ol (1)
(E)-4-Hepten-2-one (1)
(E,E,E)-1,7-diphenyl-1,3,5-heptatriene|1,7-diphenylhepta-1,3,5-triene (1)
(plusmn)12,13-DiHOME (1)
(S)-alpha-Phellandrene (1)
(Z)-2-Methyl-2-buttersaeure-(2-hydroperoxy-2-methyl-3-butenyl)ester (1)
[(1R)-1-(hydroxymethyl)-2-phosphonooxy-ethyl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate (1)
1-(4-oxo-4h-chromen-3-yl)-2,3,4,9-tetrahydro-1h-beta-carboline-3-carboxylic acid (1)
1,1-Diphenylurea (1)
1,1'-OXYBIS(4-ISOCYANATOBENZENE) (1)
1,2,4-trithiolane 4-oxide (1)
1,2-dihydro-1,2-acenaphthylenediol (1)

First Public Date

2014 (16)
2015 (13)
2025 (11)
2026 (10)
2022 (9)
2024 (8)
2023 (7)
2018 (5)
2019 (4)
2021 (3)
2017 (3)
2020 (2)
2016 (1)

Modification

15.994915 (1)
57.021464 (1)

Study status

Completed (1)

Study type

Transcription profiling by array (36)
RNA-seq of coding RNA (9)
Proteomic profiling by array (6)
Cell line - One-color microarray (1)
Antigen profiling (1)
Transcription profiling by RT-PCR (1)
Comparative genomic hybridization by array (1)
ChIP-seq (1)
Observational (1)

Release Date

2021 (314)
2022 (296)
2020 (276)
2023 (241)
2018 (235)
2017 (212)
2019 (201)
2016 (194)
2025 (193)
2024 (188)
2015 (158)
2014 (153)
2012 (123)
2013 (120)
2011 (108)
2010 (103)
2009 (70)
2008 (62)
2006 (35)
2007 (34)
2026 (32)
2004 (27)
2005 (26)
2003 (19)
1999 (18)
2000 (15)
2002 (12)
2001 (10)
1998 (7)
1997 (6)

Lab affiliation

Chemical Engineering and Biotechnology (1)
Department for Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Germany (1)
Department of Biology, Faculty of Science, Mahidol University, 272 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand. (1)
Department of Dermatology, Medical Unversity of Vienna (1)
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First ST SW, Rochester, MN 55905, USA (1)
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, The Netherlands (1)
Department of ophthalmology, experimental and translational ophthalmology, University medical center of the Johannes Gutenberg - University Mainz (1)
Divisions of Cardiology and Cardiac Surgery, McGill University Health Center, Montreal, Quebec, Canada (1)
EDyP (1)
Evolutionary and translational venomics Lab, Instituto de Biomedicina de Valencia, CSIC (1)
Group Leader Protein Dynamics ISAS e.V. Otto-Hahn-Straße 6b 44227 Dortmund, Germany (1)
Group Leader Protein Dynamics Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. Otto-Hahn-Straße 6b 44227 Dortmund, Germany (1)
Immunology, Microbiology and Parasitology Faculty of Science and Technology University of the Basque Country (UPV/EHU) Spain (1)
James Cook University, Cairns Campus, QLD Australia (1)
Laboratório de Espectrometria de Massas, Laboratório Nacional de Biociências, LNBio, CNPEM, Campinas, SP, Brazil. (1)
Plasma Proteins, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (1)
Target Discovery Institute Discovery Proteomics Facility (1)

Keyword

Stage I salivary gland cancer (1)
Stage II salivary gland cancer (1)
Metastatic squamous neck cancer with occult primary squamous cell carcinoma (1)
Stage III salivary gland cancer (1)
Stage IV salivary gland cancer (1)
Recurrent salivary gland cancer (1)
Stage III squamous cell carcinoma of the hypopharynx (1)
Stage IV squamous cell carcinoma of the hypopharynx (1)
Recurrent squamous cell carcinoma of the hypopharynx (1)
Stage III squamous cell carcinoma of the larynx (1)
Stage III verrucous carcinoma of the larynx (1)
Stage IV squamous cell carcinoma of the larynx (1)
Stage IV verrucous carcinoma of the larynx (1)
Recurrent squamous cell carcinoma of the larynx (1)
Recurrent verrucous carcinoma of the larynx (1)
Stage III squamous cell carcinoma of the paranasal sinus and nasal cavity (1)
Stage III inverted papilloma of the paranasal sinus and nasal cavity (1)
Stage III midline lethal granuloma of the paranasal sinus and nasal cavity (1)
Stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity (1)
Stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity (1)
Stage IV inverted papilloma of the paranasal sinus and nasal cavity (1)
Stage IV midline lethal granuloma of the paranasal sinus and nasal cavity (1)
Stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity (1)
Recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity (1)
Recurrent inverted papilloma of the paranasal sinus and nasal cavity (1)
Recurrent midline lethal granuloma of the paranasal sinus and nasal cavity (1)
Recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity (1)
Recurrent metastatic squamous neck cancer with occult primary (1)
Stage III squamous cell carcinoma of the lip and oral cavity (1)
Stage III basal cell carcinoma of the lip (1)

Previous page
1 / 369
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 369
Next page

Sort by:

Relevance

Page size

Cell-autonomous Inflammation of BRCA1-deficient Ovarian Cancers Drives Intrinsic Immunoreactivity and Immune Resistance through STING and VEGF

PRJNA683878 | ENA

Cell-autonomous Inflammation of BRCA1-deficient Ovarian Cancers Drives Intrinsic Immunoreactivity and Immune Resistance through STING and VEGF

BRCA1 loss leads to tumor cell transcriptional reprogramming, resulting in a DNA damage-driven, mandatory cell-autonomous type I IFN inflammatory activation mediated by STING and TREX1/2. PARP inhibition augmented this immunoreactivity, creating contextual lethality to dual immune checkpoint blockad...

ORGANISM(S): Mus musculus

2021-06-16 | GSE162935 | GEO

In Vitro Immunoreactivity Evaluation of H-Ferritin-Based Nanodrugs.

Not available

S-EPMC10197070 | biostudies-literature

Serum feline pancreatic lipase immunoreactivity and trypsin-like immunoreactivity concentrations in cats with experimentally induced chronic kidney disease.

Not available

S-EPMC8692220 | biostudies-literature

Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues.

Not available

S-EPMC2713456 | biostudies-literature

Genome Editing Reveals Idiosyncrasy of CNGA2 Ion Channel-Directed Antibody Immunoreactivity Toward Oxytocin.